Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Sell
54,925
-2,782
-5% -$599K 1.2% 17
2026
Q1
$12.6M Sell
57,707
-890
-2% -$197K 1.19% 17
2025
Q4
$13.4M Sell
58,597
-1,873
-3% -$427K 1.26% 17
2025
Q3
$14M Sell
60,470
-34
-0.1% -$6.92K 1.35% 17
2025
Q2
$11.2M Sell
60,504
-362
-0.6% -$67.3K 1.16% 20
2025
Q1
$12.8M Sell
60,866
-576
-0.9% -$112K 1.4% 16
2024
Q4
$10.9M Sell
61,442
-1,559
-2% -$287K 1.17% 17
2024
Q3
$12.4M Sell
63,001
-2,462
-4% -$459K 1.32% 15
2024
Q2
$11.2M Sell
65,463
-1,943
-3% -$322K 1.23% 17
2024
Q1
$12.3M Sell
67,406
-175
-0.3% -$30.2K 1.37% 12
2023
Q4
$10.5M Buy
67,581
+386
+0.6% +$56.3K 1.28% 16
2023
Q3
$10M Sell
67,195
-2,625
-4% -$385K 1.35% 15
2023
Q2
$9.41M Sell
69,820
-1,667
-2% -$244K 1.22% 18
2023
Q1
$11.4M Sell
71,487
-1,480
-2% -$226K 1.49% 12
2022
Q4
$11.8M Sell
72,967
-568
-0.8% -$87.1K 1.59% 12
2022
Q3
$9.87M Buy
73,535
+240
+0.3% +$34.4K 1.43% 13
2022
Q2
$11.2M Sell
73,295
-813
-1% -$124K 1.53% 14
2022
Q1
$12M Buy
74,108
+977
+1% +$142K 1.39% 14
2021
Q4
$9.9M Sell
73,131
-368
-0.5% -$43.5K 1.03% 19
2021
Q3
$7.93M Buy
73,499
+20,589
+39% +$2.35M 0.89% 28
2021
Q2
$5.96M Sell
52,910
-13,793
-21% -$1.55M 0.65% 41
2021
Q1
$7.22M Buy
66,703
+988
+2% +$106K 0.82% 30
2020
Q4
$7.04M Buy
65,715
+5,259
+9% +$505K 0.83% 29
2020
Q3
$5.29M Buy
60,456
+7,164
+13% +$674K 0.7% 37
2020
Q2
$5.23M Buy
53,292
+2,920
+6% +$257K 0.74% 36
2020
Q1
$3.84M Sell
50,372
-22,183
-31% -$1.89M 0.64% 40
2019
Q4
$6.42M Buy
72,555
+21,087
+41% +$1.75M 0.82% 30
2019
Q3
$3.9M Buy
51,468
+861
+2% +$59K 0.53% 48
2019
Q2
$3.68M Sell
50,607
-459
-0.9% -$36.1K 0.51% 54
2019
Q1
$4.12M Buy
51,066
+954
+2% +$78K 0.59% 44
2018
Q4
$4.62M Sell
50,112
-214
-0.4% -$18.8K 0.75% 37
2018
Q3
$4.76M Sell
50,326
-712
-1% -$67.5K 0.66% 44
2018
Q2
$4.73M Sell
51,038
-630
-1% -$61.5K 0.68% 41
2018
Q1
$4.89M Buy
51,668
+1,213
+2% +$133K 0.71% 42
2017
Q4
$4.88M Sell
50,455
-1,374
-3% -$129K 0.67% 43
2017
Q3
$4.61M Sell
51,829
-13,507
-21% -$1.03M 0.67% 42
2017
Q2
$4.74M Buy
65,336
+6,923
+12% +$465K 0.7% 37
2017
Q1
$3.81M Buy
58,413
+46,972
+411% +$2.95M 0.57% 51
2016
Q4
$716K Buy
11,441
+261
+2% +$15.9K 0.1% 136
2016
Q3
$705K Sell
11,180
-1,535
-12% -$99.4K 0.1% 135
2016
Q2
$787K Sell
12,715
-125
-1% -$7.62K 0.12% 127
2016
Q1
$734K Sell
12,840
-1,303
-9% -$72.6K 0.11% 126
2015
Q4
$838K Hold
14,143
0.13% 121
2015
Q3
$770K Sell
14,143
-1,100
-7% -$71.6K 0.14% 109
2015
Q2
$1.02M Sell
15,243
-1,217
-7% -$79.5K 0.17% 104
2015
Q1
$964K Sell
16,460
-1,325
-7% -$80K 0.16% 105
2014
Q4
$1.16M Sell
17,785
-1,400
-7% -$88.3K 0.2% 96
2014
Q3
$1.11M Hold
19,185
0.2% 92
2014
Q2
$1.08M Sell
19,185
-5,440
-22% -$285K 0.19% 95
2014
Q1
$1.27M Buy
24,625
+410
+2% +$20.7K 0.17% 98
2013
Q4
$1.28M Sell
24,215
-200
-0.8% -$9.83K 0.18% 94
2013
Q3
$1.09M Hold
24,415
0.17% 96
2013
Q2
$1.01M Buy
+24,415
New +$1.07M 0.13% 119

Other funds holding ABBV

Webster Bank's ABBV Position: Q2 2026 in Review

Webster Bank reduced its AbbVie (ABBV) stake by 4.8% in Q2 2026, selling an estimated $599K and leaving 54,925 shares worth $13.8M. The position accounts for 1.2% of the portfolio, ranked #17.

Webster Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $14M in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Webster Bank held 54,925 shares of AbbVie worth $13.8M as of Q2 2026.
  • Webster Bank sold 2,782 AbbVie shares in Q2 2026, an estimated $599K.
  • AbbVie made up 1.2% of Webster Bank's portfolio in Q2 2026, its #17 holding.
  • Webster Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Webster Bank's AbbVie position peaked at $14M in Q3 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.